Search Results 1341-1350 of 16797 for monoclonal antibody

  1. Clinical trials - Oncology (Medical)

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

  2. Publications - Andrew J. Bentall, M.B., Ch.B., M.D. - Mayo Clinic

    ... Antibody Is Avoided: A Matched Cohort Study. ... Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A ...

  3. Clinical trials - Oncology (Medical)

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

  4. Study Shows Halting an Enzyme Can Slow Multiple Sclerosis in Mice - Mayo Clinic News Network

    In a study published this month in Brain Pathology, the same group found that an antibody that neutralizes Kallikrein 6 is capable of staving off MS in mice.

  5. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    [antibody to hepatitis B core antigen] antibody test) are eligible. - Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase ...

  6. A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression - Mayo Clinic

    Patients with prior hypersensitivity to monoclonal antibodies. Women who are pregnant or lactating. Patients with prior treatment with MIRV or other FRα ...

  7. Debunking COVID-19 myths - Mayo Clinic

    This type of COVID-19 vaccine contains harmless S proteins. Once your immune system recognizes the S proteins, it creates antibodies and defensive white blood ...

  8. A Study to Assess the Safety and Preliminary Effectiveness of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    The purpose of this study is to evaluate the safety and preliminary effectiveness of the human anti-CD19 antibody Tafasitamab, in addition to R-CHOP ...

  9. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

    iNHL (including FL of grades 1-3A and marginal zone lymphoma) refractory to rituximab or to any other anti-CD20 monoclonal antibodies ... Prior anti-CD20 antibody ...

  10. Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients - Mayo Clinic

    ... antibodies against their donors are at a greater risk of rejection of their transplanted organs. Participation eligibility. Participant eligibility includes ...